Patents by Inventor Stuart Johnson

Stuart Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030204775
    Abstract: A modified transaction registration protocol is disclosed. The registration protocol is inherently centralized in that processes requesting registration to participate in the work of a transaction, must send a request to a Broadcast Owner CPU which is the CPU that initiated the transaction. The processes wait, suspended, until a response is received from the Broadcast Owner CPU. However, if the Broadcast Owner CPU fails to respond to the registration request, then the processes that are waiting are incapable performing work for the transaction. While a CPU failure may not occur often, in a fault-tolerant system, such events must be accounted for. Therefore, the transaction registration protocol is modified to revert to a Full Broadcast transaction protocol and complete any outstanding registration requests. This is accomplished by distributing transactions to all of the CPUs in the system, and in each CPU forcing the completion of registration requests in each CPU.
    Type: Application
    Filed: November 21, 2002
    Publication date: October 30, 2003
    Inventors: Trina R. Wisler, Jim B. Tate, David C. Hege, Charles Stuart Johnson, David J. Wisler
  • Patent number: 6553519
    Abstract: Method and apparatus for detecting signal transfer errors in a digital logic system that might occur in a transfer medium between a source device and a destination device. The method includes sending a first diagnostic signal of one or more bits from the source device through the transfer medium to the destination device; comparing the first diagnostic signal received by the destination device with a second diagnostic signal within the destination device to determine if a signal transfer error has occurred; inverting the first diagnostic signal; sending the inverted first diagnostic signal from the source device through the transfer medium to the destination device; and comparing the inverted first diagnostic signal received by the destination device with the second diagnostic signal to determine if a signal transfer error has occurred. Two embodiments of the invention are disclosed.
    Type: Grant
    Filed: October 5, 1998
    Date of Patent: April 22, 2003
    Assignee: Alcatel Internetworking (PE), Inc.
    Inventors: Jeffrey J. Walker, Greg W. Davis, C Stuart Johnson
  • Publication number: 20030074522
    Abstract: A method to record information on a data storage medium using buffered tape marks. A data storage device comprising a computer useable medium having computer readable program code disposed therein for implementing Applicants' method to record information on a data storage medium using buffered tape marks. A data storage and retrieval system comprising a computer useable medium having computer readable program code disposed therein for implementing Applicants' method to record information on a data storage medium using buffered tape marks. Computer program products embodied as program code stored in one or more memory devices, such as a magnetic disk, a magnetic tape, or other non-volatile memory device disposed in a host computer, a data storage device, and/or a library controller.
    Type: Application
    Filed: October 15, 2001
    Publication date: April 17, 2003
    Inventors: Kirby Grant Dahman, Kathryn Eileen Eldred, Gavin Stuart Johnson, Jon Arthur Lynds, Wayne Erwin Rhoten
  • Publication number: 20030065881
    Abstract: A method to record information on a data storage medium using buffered tape marks. A data storage device comprising a computer useable medium having computer readable program code disposed therein for implementing Applicants' method to record information on a data storage medium using buffered tape marks. A data storage and retrieval system comprising a computer useable medium having computer readable program code disposed therein for implementing Applicants' method to record information on a data storage medium using buffered tape marks. Computer program products embodied as program code stored in one or more memory devices, such as a magnetic disk, a magnetic tape, or other non-volatile memory device disposed in a host computer, a data storage device, and/or a library controller.
    Type: Application
    Filed: October 1, 2001
    Publication date: April 3, 2003
    Inventors: Kirby Grant Dahman, Kathryn Eileen Eldred, Gavin Stuart Johnson, Jon Arthur Lynds, Wayne Erwin Rhoten
  • Publication number: 20030065667
    Abstract: A method for fast multiple file write operations using a deferred conditional a write tape mark command and a deferred conditional tape mark indicator. A data storage and retrieval system comprising a computer useable medium having computer readable program code disposed therein for implementing Applicants' method for fast multiple file write operations. A data management system comprising computer program products embodied as program code stored in one or more memory devices, such as a magnetic disk, a magnetic tape, or another non-volatile memory device, disposed in a host computer and/or a data storage and retrieval system.
    Type: Application
    Filed: October 1, 2001
    Publication date: April 3, 2003
    Inventors: Kirby Grant Dahman, Erika Marianna Dawson, Kathryn Eileen Eldred, Gavin Stuart Johnson, Jon Arthur Lynds, James Mitchell Ratliff, Wayne Erwin Rhoten
  • Publication number: 20030065903
    Abstract: A storage management system, apparatus, and method to increase the storage capacity of data storage media. Applicants' method uses a data storage device comprising a fixed device architecture, where that data storage device is capable of operating in a first capacity mode or in a second capacity mode, and where that data storage device is capable of switching between the first capacity mode and the second capacity mode. In certain embodiments, the first capacity mode utilizes a 22 bit blockid format and the second capacity mode utilizes a 32 bit blockid format. In other embodiments, the first capacity mode utilizes a 32 bit blockid format and the second capacity mode utilizes a 22 bit blockid format.
    Type: Application
    Filed: October 1, 2001
    Publication date: April 3, 2003
    Inventors: Lyn Lequam Ashton, Kirby Grant Dahman, Erika Marianna Dawson, Kathryn Eileen Eldred, Gavin Stuart Johnson, Jon Arthur Lynds, Michael Ray Noel, James Mitchell Ratliff, Anthony Steve Pearson, Wayne Erwin Rhoten
  • Patent number: 6492160
    Abstract: Methods, recombinant host cells and kits are disclosed-for the production of members of specific binding pairs (sbp), e.g. antibodies, using display on the surface of secreted replicable genetic display packages (rgdps), e.g. filamentous phage. To produce a library of great diversity recombination occurs between first and second vectors comprising nucleic acid encoding first and second polypeptide chains of sbp members respectively, thereby producing recombinant vectors each encoding both a first and a second polypeptide chain component of a sbp member. The recombination may take place in vitro or intracellularly and may be site-specific, e.g. involving use of the loxP sequence and mutants thereof. Recombination may take place after prior screening or selecting for rgdps displaying sbp members which bind complementary sbp member of interest.
    Type: Grant
    Filed: June 25, 1998
    Date of Patent: December 10, 2002
    Assignees: Cambridge Antibody Technology Limited, Medical Research Council
    Inventors: Andrew David Griffiths, Samuel Cameron Williams, Peter Michael Waterhouse, Ahuva Nissim, Gregory Paul Winter, Kevin Stuart Johnson, Andrew John Hammond Smith
  • Patent number: 6489123
    Abstract: A method of labelling molecules which includes providing in a common medium a label molecule, a marker ligand able to bind a member of a specific binding pair, such as an antigen, a sbp member, an enzyme able to catalyze binding of the label molecule to other molecules, the enzyme being associated with the marker ligand; causing or allowing binding of the marker ligand to the sbp member; and causing or allowing binding of the label molecule to other molecules in the vicinity of the marker ligand bound to the sbp member. The marker ligand may be an antibody or any specific binding molecule, such as a chemokine or cytokine. A complementary member of the specific binding pair may be included, e.g. an antibody, or a diverse population of such sbp members, e.g. antibodies, may be included within which those which bind the counterpart sbp member, e.g. antigen, may be labelled and subsequently isolated for manipulation and/or use.
    Type: Grant
    Filed: January 23, 2001
    Date of Patent: December 3, 2002
    Assignee: Cambridge Antibody Technology Limited
    Inventors: Jane Katharine Osbourn, Elaine Joy Derbyshire, John Gerald McCafferty, Tristan John Vaughan, Kevin Stuart Johnson
  • Patent number: 6342588
    Abstract: A method of labelling molecules which includes providing in a common medium a label molecule, a marker ligand able to bind a member of a specific binding pair, such as an antigen, a sbp member, an enzyme able to catalyse binding of the label molecule to other molecules, the enzyme being associated with the marker ligand; causing or allowing binding of the marker ligand to the sbp member; and causing or allowing binding of the label molecule to other molecules in the vicinity of the marker ligand bound to the sbp member. The marker ligand may be an antibody or any specific binding molecule, such as a chemokine or cytokine. A complementary member of the specific binding pair may be included, e.g. an antibody, or a diverse population of such sbp members, e.g. antibodies, may be included within which those which bind the counterpart sbp member, e.g. antigen, may be labelled and subsequently isolated for manipulation and/or use.
    Type: Grant
    Filed: August 16, 1999
    Date of Patent: January 29, 2002
    Assignee: Cambridge Antibody Technology Limited
    Inventors: Jane Katharine Osbourn, Elaine Joy Derbyshire, John Gerald McCafferty, Tristan John Vaughan, Kevin Stuart Johnson
  • Publication number: 20020004215
    Abstract: A method of labelling molecules which includes providing in a common medium a label molecule, a marker ligand able to bind a member of a specific binding pair, such as an antigen, a sbp member, an enzyme able to catalyze binding of the label molecule to other molecules, the enzyme being associated with the marker ligand; causing or allowing binding of the marker ligand to the sbp member; and causing or allowing binding of the label molecule to other molecules in the vicinity of the marker ligand bound to the sbp member. The marker ligand may be an antibody or any specific binding molecule, such as a chemokine or cytokine. A complementary member of the specific binding pair may be included, e.g. an antibody, or a diverse population of such sbp members, e.g. antibodies, may be included within which those which bind the counterpart sbp member, e.g. antigen, may be labelled and subsequently isolated for manipulation and/or use.
    Type: Application
    Filed: January 23, 2001
    Publication date: January 10, 2002
    Applicant: Cambridge Antibody Technology, Ltd.
    Inventors: Jane Katharine Osbourn, Elaine Joy Derbyshire, John Gerald McCafferty, Tristan John Vaughan, Kevin Stuart Johnson
  • Patent number: 6291650
    Abstract: The invention provides methods and kits for producing specific binding pairs (sbp) members. Populations of polypeptide chain components of sbp members are combined to form libraries of sbps displayed by secreted replicable genetic display packages (rgdp). At least one of the polypeptide chains is expressed as a fusion with a component of an rgdp which thereby displays that polypeptide chain at the surface of rgdp. At least one population of polypeptide chains is expressed from nucleic acid which is capable of being packaged using a component of an rgdp, whereby the genetic material of rgdps produced encodes a polypeptide chain. The methods enable production of libraries of multimeric sbp members from a very large number of possible combinations. In one embodiment of the invention a method employs “chain shuffling” in the production of sbp members of desired specificity for a counterpart sbp member. Selection procedures are also described.
    Type: Grant
    Filed: June 25, 1998
    Date of Patent: September 18, 2001
    Assignees: Cambridge Antibody Technology, Ltd., Medical Research Council
    Inventors: Gregory Paul Winter, Kevin Stuart Johnson, Andrew David Griffiths, Andrew John Hammond Smith
  • Patent number: 6225447
    Abstract: Methods, recombinant host cells and kits are disclosed for the production of members of specific binding pairs (sbp), e.g. antibodies, using display on the surface of secreted replicable genetic display packages (rgdps), e.g. filamentous phage. To produce a library of great diversity, recombination occurs between first and second vectors comprising nucleic acid encoding first and second polypeptide chains of sbp members respectively, thereby producing recombinant vectors each encoding both a fist and a second polypeptide chain component of an sbp member. The recombination may take place in vitro or intracellularly and may be site-specific, e.g. involving use of the loxP sequence and mutants thereof. Recombination may take place after prior screening or selecting for rgdps displaying sbp members which bind complementary sbp member of interest.
    Type: Grant
    Filed: June 17, 1998
    Date of Patent: May 1, 2001
    Assignees: Cambridge Antibody Technology Ltd., Medical Research Council
    Inventors: Gregory Paul Winter, Kevin Stuart Johnson, Andrew David Griffiths, Andrew John Hammond Smith
  • Patent number: 6180336
    Abstract: A method of labelling molecules which includes providing in a common medium a label molecule, a marker ligand able to bind a member of a specific binding pair, such as an antigen, a sbp member, an enzyme able to catalyse binding of the label molecule to other molecules, the enzyme being associated with the marker ligand; causing or allowing binding of the marker ligand to the sbp member; and causing or allowing binding of the label molecule to other molecules in the vicinity of the marker ligand bound to the sbp member. The marker ligand may be an antibody or any specific binding molecule, such as a chemokine or cytokine. A complementary member of the specific binding pair may be included, e.g. an antibody, or a diverse population of such sbp members, e.g. antibodies, may be included within which those which bind the counterpart sbp member, e.g. antigen, may be labelled and subsequently isolated for manipulation and/or use.
    Type: Grant
    Filed: June 17, 1998
    Date of Patent: January 30, 2001
    Assignee: Cambridge Antibody Technology Limited
    Inventors: Jane Katharine Osbourn, Elaine Joy Derbyshire, John Gerald McCafferty, Tristan John Vaughan, Kevin Stuart Johnson
  • Patent number: 6172197
    Abstract: A member of a specific binding pair (sbp) is identified by expressing DNA encoding a genetically diverse population of such sbp members in recombinant host cells in which the sbp members are displayed in functional form at the surface of a secreted recombinant genetic display package (rgdp) containing DNA encoding the sbp member or a polypeptide component thereof, by virtue of the sbp member or a polypeptide component thereof being expressed as a fusion with a capsid component of the rgdp. The displayed sbps may be selected by affinity with a complementary sbp member, and the DNA recovered from selected rgdps for expression of the selected sbp members. Antibody sbp members may be thus obtained, with the different chains thereof expressed, one fused to the capsid component and the other in free form for association with the fusion partner polypeptide. A phagemid may be used as an expression vector, with said capsid fusion helping to package the phagemid DNA.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: January 9, 2001
    Assignees: Medical Research Council, Cambridge Antibody Technology Limited
    Inventors: John McCafferty, Anthony Richard Pope, Kevin Stuart Johnson, Henricus Renerus Jacobus Mattheus Hoogenboom, Andrew David Griffiths, Ronald Henry Jackson, Kaspar Philipp Holliger, James David Marks, Timothy Piers Clackson, David John Chiswell, Gregory Paul Winter, Timothy Peter Bonnert
  • Patent number: 6140471
    Abstract: Methods, recombinant host cells and kits are disclosed for the production of members of specific binding pairs (sbp), e.g. antibodies, using display on the surface of secreted replicable genetic display packages (rgdps), e.g. filamentous phage. To produce a library of great diversity, recombination occurs between first and second vectors comprising nucleic acid encoding first and second polypeptide chains of sbp members respectively, thereby producing recombinant vectors each encoding both a first and a second polypeptide chain component of an sbp member. The recombination may take place in vitro or intracellularly and may be site-specific, e.g. involving use of the loxP sequence and mutants thereof. Recombination may take place after prior screening or selecting for rgdps displaying sbp members which bind complementary sbp member of interest.
    Type: Grant
    Filed: March 30, 1998
    Date of Patent: October 31, 2000
    Assignees: Cambridge Antibody Technology, Ltd., Medical Research Council
    Inventors: Kevin Stuart Johnson, Gregory Paul Winter, Andrew David Griffiths, Andrew John Hammond Smith, Peter Michael Waterhouse
  • Patent number: 5994519
    Abstract: A method of labelling molecules which includes providing in a common medium a label molecule, a marker ligand able to bind a member of a specific binding pair, such as an antigen, a sbp member, an enzyme able to catalyse binding of the label molecule to other molecules, the enzyme being associated with the marker ligand; causing or allowing binding of the marker ligand to the sbp member; and causing or allowing binding of the label molecule to other molecules in the vicinity of the marker ligand bound to the sbp member. The marker ligand may be an antibody or any specific binding molecule, such as a chemokine or cytokine. A complementary member of the specific binding pair may be included, e.g. an antibody, or a diverse population of such sbp members, e.g. antibodies, may be included within which those which bind the counterpart sbp member, e.g. antigen, may be labelled and subsequently isolated for manipulation and/or use.
    Type: Grant
    Filed: July 8, 1997
    Date of Patent: November 30, 1999
    Assignee: Cambridge Antibody Technology Limited
    Inventors: Jane Katharine Osbourn, Elaine Joy Derbyshire, John Gerald McCafferty, Tristan John Vaughan, Kevin Stuart Johnson
  • Patent number: 5980907
    Abstract: Attenuated microorganism for use in immunoprophylaxis in which the attenuation is brought about by the presence of a mutation in the DNA sequence of the microorganism which encodes, or which regulates the expression of DNA encoding a protein that is produced in response to environmental stress, the microorganism optionally being capable of expressing DNA encoding a heterologous antigen.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: November 9, 1999
    Assignee: Glaxo Wellcome Inc.
    Inventors: Gordan Dougan, Ian George Charles, Carlos Estenio Hormaeche, Kevin Stuart Johnson, Steven Neville Chatfield
  • Patent number: 5977319
    Abstract: The invention relates to specific binding members for estradiol and materials and methods relating thereto, in particular antibodies or binding domains thereof which have high affinities (low dissociation constants) for estradiol and low cross-reactivity for other steroids. The invention further provides means to make such binding members, assay methods for the detection and/or quantitation of estradiol, and nucleic acid encoding said binding members, which nucleic acid may be used for their production. Preferred binding members include those with CDR regions of the D12 antibody heavy and light chain domains (SEQ ID NO:2 and SEQ ID NO:12 respectively).
    Type: Grant
    Filed: October 21, 1997
    Date of Patent: November 2, 1999
    Assignee: Cambridge Antibody Technology Limited
    Inventors: Anthony Richard Pope, Kevin Pritchard, Andrew James Williams, Kevin Stuart Johnson
  • Patent number: 5969108
    Abstract: A member of a specific binding pair (sbp) is identified by expressing DNA encoding a genetically diverse population of such sbp members in recombinant host cells in which the sbp members are displayed in functional form at the surface of a secreted recombinant genetic display package (rgdp) containing DNA encoding the sbp member or a polypeptide component thereof, by virtue of the sbp member or a polypeptide component thereof being expressed as a fusion with a capsid component of the rgdp. The displayed sbps may be selected by affinity with a complementary sbp member, and the DNA recovered from selected rgdps for expression of the selected sbp members. Antibody sbp members may be thus obtained, with the different chains thereof expressed, one fused to the capsid component and the other in free form for association with the fusion partner polypeptide. A phagemid may be used as an expression vector, with said capsid fusion helping to package the phagemid DNA.
    Type: Grant
    Filed: January 8, 1993
    Date of Patent: October 19, 1999
    Assignees: Medical Research Council, Cambridge Antibody Technology Limited
    Inventors: John McCafferty, Anthony Richard Pope, Kevin Stuart Johnson, Henricus Renerus Jacobus Mattheus Hoogenboom, Andrew David Griffiths, Ronald Henry Jackson, Kaspar Philipp Holliger, James David Marks, Timothy Piers Clackson, David John Chiswell, Gregory Paul Winter, Timothy Peter Bonnert
  • Patent number: 5962255
    Abstract: Methods, recombinant host cells and kits are disclosed for the production of members of specific binding pairs (sbp), e.g. antibodies, using display on the surface of secreted replicable genetic display packages (rgdps), e.g. filamentous phage. To produce a library of great diversity recombination occurs between first and second vectors comprising nucleic acid encoding first and second polypeptide chains of sbp members respectively, thereby producing recombinant vectors each encoding both a first and a second polypeptide chain component of a sbp member. The recombination may take place in vitro or intracellularly and may be site-specific, e.g. involving use of the loxP sequence and mutants thereof. Recombination may take place after prior screening or selecting for rgdps displaying sbp members which bind complementary sbp member of interest.
    Type: Grant
    Filed: December 5, 1994
    Date of Patent: October 5, 1999
    Assignees: Cambridge Antibody Technology Limited, Medical Research Council
    Inventors: Andrew David Griffiths, Samuel Cameron Williams, Peter Michael Waterhouse, Ahuva Nissim, Gregory Paul Winter, Kevin Stuart Johnson, Andrew John Hammond Smith